These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 30896821)
1. The expression, significance and function of cancer susceptibility candidate 9 in lung squamous cell carcinoma: A bioinformatics and in vitro investigation. Gao L; Guo YN; Zeng JH; Ma FC; Luo J; Zhu HW; Xia S; Wei KL; Chen G Int J Oncol; 2019 May; 54(5):1651-1664. PubMed ID: 30896821 [TBL] [Abstract][Full Text] [Related]
2. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2. Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of miRNA‑1 and its potential target gene network in lung squamous cell carcinoma. Li X; Qin M; Huang J; Ma J; Hu X Mol Med Rep; 2019 Jun; 19(6):5063-5078. PubMed ID: 31059033 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma. Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811 [TBL] [Abstract][Full Text] [Related]
5. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR. Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the HOXA11 level in patients with lung squamous cancer and insights into potential molecular pathways via bioinformatics analysis. Zhang R; Zhang TT; Zhai GQ; Guo XY; Qin Y; Gan TQ; Zhang Y; Chen G; Mo WJ; Feng ZB World J Surg Oncol; 2018 Jun; 16(1):109. PubMed ID: 29914539 [TBL] [Abstract][Full Text] [Related]
7. Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis. Xie ZC; Li TT; Gan BL; Gao X; Gao L; Chen G; Hu XH Pathol Res Pract; 2018 May; 214(5):644-654. PubMed ID: 29650443 [TBL] [Abstract][Full Text] [Related]
8. Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation. Luo J; Shi K; Yin SY; Tang RX; Chen WJ; Huang LZ; Gan TQ; Cai ZW; Chen G World J Surg Oncol; 2018 Apr; 16(1):76. PubMed ID: 29636077 [TBL] [Abstract][Full Text] [Related]
9. Identification of crucial regulatory relationships between long non-coding RNAs and protein-coding genes in lung squamous cell carcinoma. Wu X; Ruan L; Yang Y; Mei Q Mol Cell Probes; 2016 Jun; 30(3):146-52. PubMed ID: 26928440 [TBL] [Abstract][Full Text] [Related]
10. Bioinformatics analyses of the differences between lung adenocarcinoma and squamous cell carcinoma using The Cancer Genome Atlas expression data. Sun F; Yang X; Jin Y; Chen L; Wang L; Shi M; Zhan C; Shi Y; Wang Q Mol Med Rep; 2017 Jul; 16(1):609-616. PubMed ID: 28560415 [TBL] [Abstract][Full Text] [Related]
11. LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma. Liu B; Chen Y; Yang J Oncotarget; 2017 Apr; 8(15):24275-24291. PubMed ID: 27903974 [TBL] [Abstract][Full Text] [Related]
12. LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer. Luo K; Geng J; Zhang Q; Xu Y; Zhou X; Huang Z; Shi KQ; Pan C; Wu J J Exp Clin Cancer Res; 2019 Jun; 38(1):249. PubMed ID: 31186036 [TBL] [Abstract][Full Text] [Related]
13. Pyroptosis-related long-noncoding RNA signature predicting survival and immunotherapy efficacy in patients with lung squamous cell carcinoma. Zhan X; Li J; Ding Y; Zhou F; Zeng R; Lei L; Zhang Y; Feng A; Qu Y; Yang Z Clin Exp Med; 2024 Jul; 24(1):145. PubMed ID: 38960987 [TBL] [Abstract][Full Text] [Related]
14. Multiple mutations of lung squamous cell carcinoma shared common mechanisms. Li Q; Hou J; Hu Z; Gu B; Shi Y Oncotarget; 2016 Nov; 7(48):79629-79636. PubMed ID: 27835590 [TBL] [Abstract][Full Text] [Related]
15. Role of downregulated ADARB1 in lung squamous cell carcinoma. Wang X; Ren X; Liu W; Chen X; Wei J; Gong Z; Yan Y; Xu Z Mol Med Rep; 2020 Mar; 21(3):1517-1526. PubMed ID: 32016472 [TBL] [Abstract][Full Text] [Related]
16. LINC01936 inhibits the proliferation and metastasis of lung squamous cell carcinoma probably by EMT signaling and immune infiltration. Tian Q; Liu X; Li A; Wu H; Xie Y; Zhang H; Wu F; Chen Y; Bai C; Zhang X PeerJ; 2023; 11():e16447. PubMed ID: 38084139 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis. Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858 [TBL] [Abstract][Full Text] [Related]
18. lncRNA CASC9 positively regulates CHK1 to promote breast cancer cell proliferation and survival through sponging the miR‑195/497 cluster. Shao G; Wang M; Fan X; Zhong L; Wang Z; Zhang P; Ji S Int J Oncol; 2019 May; 54(5):1665-1675. PubMed ID: 30816435 [TBL] [Abstract][Full Text] [Related]
19. PLAU, transcriptionally negatively regulated by GATA6, promotes lung squamous carcinoma cell proliferation and migration. Guo J; Wang H; Huang C; Lai C; Shang W; Luo S; Chen L Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119744. PubMed ID: 38702016 [TBL] [Abstract][Full Text] [Related]
20. NCK1-AS1 promotes the progression of lung squamous cell carcinoma through transcriptionally upregulating NCK1 via interacting with MYC. Zhou X; Bao W; Zhang D; Yang Y; Du X; Qiu G Cancer Biol Ther; 2021 Mar; 22(3):196-203. PubMed ID: 33629937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]